Faheem Hasnain insider trades
Open-market stock purchases and sales by Faheem Hasnain, President & CEO at Gossamer Bio, Inc, from SEC Form 4 filings since Apr 20, 2010.
Track record: 33% of 3 scored buys are up 5% or more since purchase, averaging -4%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 24, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $166K |
| Aug 24, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | — |
| Jun 4, 2026 | KURA Kura Oncology, Inc | Bought (not open market) | — |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $19.6K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $4.8M |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $1.7M |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $1.3M |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $367K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $1.2M |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $7.8M |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $3.2M |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $569K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Sold (not open market) | $961K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $756K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $693K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $591K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $197K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $245K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $293K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $146K |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | $21.1K |
| Jan 2, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | — |
| Jan 2, 2026 | GOSS Gossamer Bio, Inc | Bought (not open market) | — |
| Dec 9, 2025 | KURA Kura Oncology, Inc | Bought (not open market) | $31.2K |
| Dec 9, 2025 | KURA Kura Oncology, Inc | Sold | $110K |
Companies traded
- GOSS Gossamer Bio, Inc: 7 buys, 2 sales, last Aug 24, 2026
- KURA Kura Oncology, Inc: 2 sales, last Jun 4, 2026
- MRTX Mirati Therapeutics, Inc: 1 buy, last Jan 23, 2024
- NUVB Nuvation Bio Inc: other filings, last Feb 10, 2021
- TOCA Tocagen Inc: 4 buys, last Oct 4, 2019
- VTL Vital Therapies Inc: 2 buys, 2 sales, last Sep 13, 2018
- RCPT Receptos, Inc: 2 sales, last Aug 27, 2015
- NONE Kura Oncology, Inc: other filings, last Apr 23, 2015
- AMBI Ambit Biosciences Corp: other filings, last Nov 10, 2014
- SOMX Pernix Sleep, Inc: other filings, last Mar 6, 2013
- FACT Facet Biotech Corp: other filings, last Apr 21, 2010